Prospects of Nanocarriers for Oral Delivery of Bioactives Using Targeting Strategies.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Current Pharmaceutical Biotechnology

• Publication date

  2016-06-30

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.2174/1389201017666160401145608PMID 27033507
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Styrene maleic acid micelles as a nanocarrier system for oral anticancer drug delivery – dual uptake through enterocytes and M-cells

  2015cited by this paper
• Vaccine delivery carriers: insights and future perspectives.

  2013cited by this paper
• Pharmaceutical nanotechnology for oral delivery of anticancer drugs.

  2013cited by this paper
• Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for Improvement

  2013cited by this paper
• Oral delivery of anticancer drugs: challenges and opportunities.

  2013cited by this paper
• Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow.

  2012cited by this paper
• Large intestine-targeted nanoparticle-releasing oral vaccine to control genitorectal viral infection

  2012cited by this paper
• Gut-associated lymphoid tissues for the development of oral vaccines.

  2012cited by this paper
• Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel.

  2012cited by this paper
• Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.

  2012cited by this paper
• Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.

  2012cited by this paper
• Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: effect of silica architecture on immunological properties.

  2012cited by this paper
• Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.

  2012cited by this paper
• Oral delivery of doxorubicin using novel polyelectrolyte-stabilized liposomes (layersomes).

  2012cited by this paper
• Transcytosis of Listeria monocytogenes across the intestinal barrier upon specific targeting of goblet cell accessible E-cadherin

  2011cited by this paper
• Mucoadhesive drug delivery systems

  2011cited by this paper
• Mucosal Macrophages in Intestinal Homeostasis and Inflammation

  2011cited by this paper
• The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles.

  2011cited by this paper
• Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.

  2011cited by this paper
• The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery.

  2011cited by this paper
• Biodegradable polymeric nanoparticles based drug delivery systems.

  2010cited by this paper
• Endocytosis of nanomedicines.

  2010cited by this paper
• Barrier properties of gastrointestinal mucus to nanoparticle transport.

  2010cited by this paper
• Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery.

  2010cited by this paper
• Nanocarriers’ entry into the cell: relevance to drug delivery

  2009cited by this paper
• Targeted Delivery of Immunogen to Primate M Cells with Tetragalloyl Lysine Dendrimer1

  2009cited by this paper
• Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination.

  2009cited by this paper
• Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery.

  2009cited by this paper
• Expression of short-chain fatty acid receptor GPR41 in the human colon.

  2009cited by this paper
• Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.

  2009cited by this paper
• PEGylation as a tool for the biomedical engineering of surface modified microparticles.

  2008cited by this paper
• Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice

  2008cited by this paper
• Identification of a peptide sequence that improves transport of macromolecules across the intestinal mucosal barrier targeting goblet cells.

  2008cited by this paper
• Nanoparticle strategies for the oral delivery of insulin

  2008cited by this paper
• M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis.

  2008cited by this paper
• Vitamin B12 as a Carrier for the Oral Delivery of Insulin

  2007cited by this paper
• Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery.

  2007cited by this paper
• Comparison of Oral Insulin Spray and Subcutaneous Regular Insulin at Mealtime in Type 1 Diabetes

  2007cited by this paper
• M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B

  2007cited by this paper
• A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin.

  2007cited by this paper
• Development of Biodegradable Nanoparticles for Oral Delivery of Ellagic Acid and Evaluation of Their Antioxidant Efficacy Against Cyclosporine A-Induced Nephrotoxicity in Rats

  2007cited by this paper
• Reversible differentiation of Caco-2 cells reveals galectin-9 as a surface marker molecule for human follicle-associated epithelia and M cell-like cells.

  2007cited by this paper
• An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells.

  2007cited by this paper
• Oral insulin delivery by means of solid lipid nanoparticles

  2007cited by this paper
• Bioadhesive capacity and immunoadjuvant properties of thiamine-coated nanoparticles.

  2007cited by this paper
• Local treatment of experimental colitis in the rat by negatively charged liposomes of catalase, TMN and SOD

  2006cited by this paper
• Peyer's Patches and M Cells as Potential Sites of the Inflammatory Onset in Crohn's Disease

  2006cited by this paper
• Gold nanoparticles as carriers for efficient transmucosal insulin delivery.

  2006cited by this paper
• Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.

  2006cited by this paper
• Enterocyte TLR4 Mediates Phagocytosis and Translocation of Bacteria Across the Intestinal Barrier

  2006cited by this paper
• Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.

  2006cited by this paper
• Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree.

  2006cited by this paper
• Salmonella-like bioadhesive nanoparticles.

  2005cited by this paper
• Keynote review: epithelial and endothelial barriers in human disease.

  2005cited by this paper
• A Novel Strategy for the Enhancement of Drug Absorption Using a Claudin Modulator

  2005cited by this paper
• Exploiting the vitamin B12 pathway to enhance oral drug delivery via polymeric micelles.

  2005cited by this paper
• Immunity in response to particulate antigen-delivery systems.

  2005cited by this paper
• Characterization of surface-modified nanoparticles for in vivo biointeraction. A sedimentation field flow fractionation study.

  2005cited by this paper
• Transmucosal macromolecular drug delivery.

  2005cited by this paper
• Oral solid lipid nanoparticle-based antitubercular chemotherapy.

  2005cited by this paper
• Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

  2005cited by this paper
• Local and systemic activity of the polysaccharide chitosan at lymphoid tissues after oral administration

  2005cited by this paper
• Cell culture-based models for intestinal permeability: a critique.

  2005cited by this paper
• Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles.

  2004cited by this paper
• Calcium phosphate-PEG-insulin-casein (CAPIC) particles as oral delivery systems for insulin.

  2004cited by this paper
• A Method for Oral DNA Delivery with N-Acetylated Chitosan

  2004cited by this paper
• Effect of Chitosan on Epithelial Cell Tight Junctions

  2004cited by this paper
• The Madin Darby Canine Kidney (MDCK) Epithelial Cell Monolayer as a Model Cellular Transport Barrier

  2004cited by this paper
• Intestinal Epithelial Cells Control Dendritic Cell Function

  2004cited by this paper
• Functionalisation of allergen-loaded microspheres with wheat germ agglutinin for targeting enterocytes.

  2004cited by this paper
• Utilizing Bacterial Mechanisms of Epithelial Cell Entry: Invasin-induced Oral Uptake of Latex Nanoparticles

  2004cited by this paper
• A novel per‐oral insulin formulation: proof of concept study in non‐diabetic subjects

  2004cited by this paper
• M cell targeting with Aleuria aurantia lectin as a novel approach for oral allergen immunotherapy.

  2004cited by this paper
• The promise of gene therapy in gastrointestinal and liver diseases

  2003cited by this paper
• Pathological interactions of bacteria and toxins with the gastrointestinal epithelial tight junctions and/or the zonula adherens: an update.

  2003cited by this paper
• Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems.

  2003cited by this paper
• The viral sigma1 protein and glycoconjugates containing alpha2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces.

  2003cited by this paper
• Prediction of the Oral Absorption of Low-Permeability Drugs Using Small Intestine-Like 2/4/A1 Cell Monolayers

  2003cited by this paper
• Selective Adherence of IgA to Murine Peyer’s Patch M Cells: Evidence for a Novel IgA Receptor1

  2002cited by this paper
• Biodegradable microparticles for the mucosal delivery of antibacterial and dietary antigens.

  2002cited by this paper
• LIPOSOME (LIPODINE™)-MEDIATED DNA VACCINATION BY THE ORAL ROUTE

  2002cited by this paper
• Development of oral insulin: progress and current status

  2002cited by this paper
• The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist™ System

  2002cited by this paper
• Mucins in the gastrointestinal tract in health and disease.

  2001cited by this paper
• Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment.

  2001cited by this paper
• Mucoadhesive nanoparticulate systems for peptide drug delivery.

  2001cited by this paper
• Transport of Lipophilic Drug Molecules in a New Mucus-Secreting Cell Culture Model Based on HT29-MTX Cells

  2001cited by this paper
• Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa

  2001cited by this paper
• The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo.

  2001cited by this paper
• Oral Delivery of Taxanes

  2001cited by this paper
• Tetanus Toxoid Loaded Nanoparticles from Sulfobutylated Poly(Vinyl Alcohol)-Graft-Poly(Lactide-co-Glycolide): Evaluation of Antibody Response After Oral and Nasal Application in Mice

  2001cited by this paper
• Cystic fibrosis sputum: a barrier to the transport of nanospheres.

  2000cited by this paper
• Current methodologies used for evaluation of intestinal permeability and absorption.

  2000cited by this paper
• Delivery Systems for Gene-based Vaccines

  2000cited by this paper
• Oral Immunization with Helicobacter pylori‐Loaded Poly( d, l‐Lactide‐Co‐Glycolide) Nanoparticles

  1999cited by this paper
• Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy

  1999cited by this paper
• MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening.

  1999cited by this paper
• Mucosal immunity and tolerance: relevance to vaccine development

  1999cited by this paper
• Effect of chitosan on epithelial permeability and structure.

  1999cited by this paper
• Human Intestinal M Cells Display the Sialyl Lewis A Antigen

  1999cited by this paper

• Nanoencapsulation of chitooligosaccharides enhances its oral bioavailability and anti-liver fibrotic effects.

  2022cites this paper
• Metal-organic frameworks for advanced drug delivery

  2021cites this paper
• Fabrication of Mucoadhesive-Dendrimers as Solid Dosage Forms.

  2019cites this paper